PT - JOURNAL ARTICLE AU - Martinez, Magaly AU - Nguyen, Phuong-Vi AU - Su, Maxwell AU - Cardozo, Fátima AU - Valenzuela, Adriana AU - Franco, Laura AU - Galeano, María Eugenia AU - Rojas, Leticia Elizabeth AU - Díaz Acosta, Chyntia Carolina AU - Fernández, Jonás AU - Ortiz, Joel AU - Puerto, Florencia del AU - Mendoza, Laura AU - Nara, Eva AU - Rojas, Alejandra AU - Waggoner, Jesse J. TI - SARS-CoV-2 variants in Paraguay: Detection and surveillance with a readily modifiable, multiplex real-time RT-PCR AID - 10.1101/2021.09.15.21263618 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.15.21263618 4099 - http://medrxiv.org/content/early/2021/09/20/2021.09.15.21263618.short 4100 - http://medrxiv.org/content/early/2021/09/20/2021.09.15.21263618.full AB - Objectives The objective of the current study was to develop a lower-cost and scalable protocol to identify and monitor SARS-CoV-2 variants in Paraguay by pairing real-time RT-PCR detection of spike mutations with amplicon Sanger sequencing and whole-genome Nanopore sequencing.Methods 201 acute-phase nasopharyngeal samples from SARS-CoV-2-positive individuals were tested with two rRT-PCRs: 1) N2RP assay to confirm SARS-CoV-2 RNA detection (CDC N2 target), and 2) the Spike SNP assay to detect mutations in the spike receptor binding domain. The assay was performed with probes to identify mutations associated with the following variants: alpha (501Y), beta/gamma (417variant/484K/501Y), delta (452R/478K), and lambda (452Q/490S).Results All samples were positive for SARS-CoV-2 in the N2RP assay (mean Ct, 20.8; SD 5.6); 198/201 (98.5%) tested positive in the Spike SNP assay. The most common genotype was 417variant/484K/501Y, detected in 102/198 samples (51.5%) and most consistent with P.1 lineage (gamma variant) in Paraguay. No mutations (K417 only) were found in 64/198 (32.3%); and K417/484K was identified in 22/198 (11.1%), consistent with P.2 (zeta). Seven samples (3.5%) tested positive for 452R without 478K, and one sample with genotype K417/501Y was confirmed as B.1.1.7 (alpha). Results were confirmed by Sanger sequencing in 181/181 samples (100%) with high-quality amplicon sequences, and variant calls were consistent with Nanopore sequencing in 29/29 samples.Conclusions The Spike SNP assay provides accurate detection of mutations associated with SARS-CoV-2 variants. This can be implemented in laboratories performing rRT-PCR to improve population-level surveillance for these mutations and inform the judicious use of scarce sequencing resources.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially funded by Consejo Nacional de Ciencia y Tecnologia with FEEI support, CONACYT, Paraguay; PINV20-239 (MM) and the Doris Duke Charitable Foundation, Clinical Scientist Development Award 2019089478 (JJW)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed and approved by the IICS Scientific and Ethics Committee (P38/2020) and the Emory Institutional Review Board (study 00110736).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon request following acceptance of this manuscript for publication.